Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse Population
Malignant Neoplasm of Large Intestine
About this trial
This is an interventional prevention trial for Malignant Neoplasm of Large Intestine focused on measuring colorectal cancer screening, fecal occult blood testing (FOBT), vulnerable populations, community health center
Eligibility Criteria
Inclusion Criteria:
Ages 50 to 80 as of 12/31/2009 At least 2 visits to the community health center between 7/1/2008 and 12/31/2009
Exclusion criteria:
Documented fecal occult blood testing (FOBT) within 1 year (between 1/1/2009 and 12/31/2009) Documented sigmoidoscopy within 5 years (between 1/1/2005 and 12/31/2009) Documented colonoscopy within 10 years (between 1/1/2000 and 12/31/2009)
Sites / Locations
- Heartland International Health Center
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
usual care
Care manager outreach
Patients assigned to the usual care arm may be referred for colorectal cancer screening by their providers per usual health center protocol and practice. They receive no additional outreach by the preventive care care manager.
Patients assigned to the intervention arm are mailed a letter informing them that they are due for colorectal cancer screening, educational information about colorectal cancer screening, a fecal occult blood testing (FOBT) kit, and directions on how to complete and return the FOBT kit